NASDAQ:VREX - Nasdaq - US92214X1063 - Common Stock - Currency: USD
12.64
-0.21 (-1.63%)
The current stock price of VREX is 12.64 USD. In the past month the price decreased by -11.24%. In the past year, price decreased by -26.55%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2017-01-20. The firm operates through two segments: Medical and Industrial. The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, three-dimensional (3D) reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications. The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in various other markets.
VAREX IMAGING CORP
1678 S Pioneer Rd
Salt Lake City UTAH 84104 US
CEO: Sunny S. Sanyal
Employees: 2300
Company Website: https://www.vareximaging.com/
Investor Relations: https://www.vareximaging.com/investor-relations/
Phone: 18019725000
The current stock price of VREX is 12.64 USD. The price decreased by -1.63% in the last trading session.
The exchange symbol of VAREX IMAGING CORP is VREX and it is listed on the Nasdaq exchange.
VREX stock is listed on the Nasdaq exchange.
11 analysts have analysed VREX and the average price target is 21.62 USD. This implies a price increase of 71.08% is expected in the next year compared to the current price of 12.64. Check the VAREX IMAGING CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
VAREX IMAGING CORP (VREX) has a market capitalization of 520.77M USD. This makes VREX a Small Cap stock.
VAREX IMAGING CORP (VREX) currently has 2300 employees.
VAREX IMAGING CORP (VREX) has a support level at 12.45 and a resistance level at 13.57. Check the full technical report for a detailed analysis of VREX support and resistance levels.
The Revenue of VAREX IMAGING CORP (VREX) is expected to grow by 2.79% in the next year. Check the estimates tab for more information on the VREX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VREX does not pay a dividend.
VAREX IMAGING CORP (VREX) will report earnings on 2025-04-30, after the market close.
The PE ratio for VAREX IMAGING CORP (VREX) is 22.57. This is based on the reported non-GAAP earnings per share of 0.56 and the current share price of 12.64 USD. Check the full fundamental report for a full analysis of the valuation metrics for VREX.
The outstanding short interest for VAREX IMAGING CORP (VREX) is 2.1% of its float. Check the ownership tab for more information on the VREX short interest.
ChartMill assigns a fundamental rating of 4 / 10 to VREX. Both the profitability and the financial health of VREX get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months VREX reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by -50.88% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -3.57% | ||
ROE | -8.79% | ||
Debt/Equity | 1.06 |
ChartMill assigns a Buy % Consensus number of 84% to VREX. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 6.78% and a revenue growth 2.79% for VREX